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We have developed a new multienzyme control serum, Seraclear-HE, which was designed to function not only as an accuracy and precision control serum but also as an intermethod calibrator for unifying interlaboratory clinical enzyme data in terms of reference method values. Seraclear (14) . In Japan, laboratories can select a reagent for an enzyme analyte from a variety of kits, which are based on various methodologies from many suppliers.
Further, no restrictions have been placed on the reporting unit and temperature of measurement. These points are reflected in the results of the comprehensive survey of 1992 carried out by the Japan Medical Association for several enzymes; the survey included results of all methods, units, and temperatures of measurement ( Table 1 ). All of the four lyophilized samples assayed showed similar overall interlaboratory variation (CV,%) for the raw data. Both preparations were sterilized by ifitration through the micropore filters. The total number of vials of one lot was 10 000-11 000 each (Normal and Abnormal).
For a quality check, we weighed >30 vials in each lot after filling (3.0 mL). The bottles were immediately cooled to below -35#{176}C and lyophilized (final pressure 0.1 mmHg, final temperature 25#{176}C). At the end of the process, sterile nitrogen gas was introduced into the lyophilization chamber to ambient pressure, the vials were closed with stoppers, and then were sealed with aluminum caps. The residual moisture was about 1% by weight. Homogeneity studies were carried out throughout the filling process by weighing the reconstituted material and measuring the seven enzyme activities in duplicate for 15 to 20 vials taken at random from the manufactured batch. Measuring the enzyme activities in our laboratory by using the commercial reagent kits at 37#{176}C showed that the losses in activities during lyophilization were within 5% for all seven enzymes.
The production process for Seraclear-HE is summarized in Fig. 2 We measured six enzymes by the IFCC and SFBC Reference Methods as mentioned above at 30#{176}C for 4.5 years. The stability of the enzyme activity in reconstituted material at 10#{176}C and 37#{176}C within the same working day was examined by measuring with the analyzer, in duplicate, at 1-h intervals for 6 h. The exposed samples were stored at -20#{176}C before assay.
Results

Choice of Source of Added Enzymes
Preliminary experiments showed that all human cell lines tested exhibited very high AST and LD activity, but more than half of the AST obtained from these cell lines was of the mitochondrial type (m-AST). In contrast, nearly all of the AST activity from erythrocytes was that of the cytosolic fraction (s-AST). Therefore, we purified AST from human erythrocytes and obtained LD as a byproduct of this AST purification. Nearly all cell lines showed faint ALT activity, but only hepatoma cell lines, e.g., KN, HuH-6, and Hep G2, produced ALT at relatively high amounts (Table 3) . Thus, we chose the highest ALT-producing hepatoma cell line (KN) as the ALT production source. Although many cell lines produce a high concentration of ALP, the kinetic properties are unlike those of the isoenzymes in human serum (30) , being instead heat-stable and L-phenylalanine-sensitive tumor types. At the first screening, however, ALP from the FL cell
Enzyme activity, kU/L Despite reports on AMY-producing tumors (32) , all of the human cell lines used in the AMY expression study showed activities too weak to be used for enzyme production.
On the other hand, salivary AMY activity was highest in saliva. We found human urine to be a moderately rich source of pancreatic AMY. Therefore, we decided to produce AMY from human urine and saliva. Overall, although the electrophoresis patterns of the selected enzymes were somewhat different from those of human sera, especially for CK and ALP (Fig. 3) (Table 6 ). Table 7 shows the variability of enzyme activities measured in 20 reconstituted specimens. The Table 6 . Homogeneity of the vial-filling process.
between-vial CVs of these enzymes were <2.5%, i.e., at 37#{176}C, the materials were stable throughout a routine working day except for the CK (Table 9) .
________________________________________________
After reconstitution, CK activity in liquid form de- Table 7 . Catalytic concentration of each enzyme creased at 37#{176}C within 3 h. measured in reconstituted material.
Physicochemical
properties.
The viscosity of the con- The goal of our study was to develop a secondary ERM that could be used as an intermethod calibrator The cell lines differed from each other not only in morphology and growth kinetics, but also in enzyme productivities, especially for ALP, ALT, GOT, and CK activity (Table 3) . After a long, discouraging screening test, we finally identified human cell strains suitable for the production of ALT, ALP, CK, and GOT. The Michaelis constants of the enzymes produced were almost the same as those from human serum (21) , but the isoenzyme patterns of CK and ALP differed from those of the enzymes in normal human serum (Fig. 3) . The ALP from human amnion cells, used in Seraclear-HE, has properties that resemble those of human placenta and intestine.
We are now screening hepatocyte-origin strains, osteosarcoma strains, and others for cell lines that produce ALP with properties that more closely resemble those of ALP from human liver or bone. Some cell lines showed relatively high CK activities, but the major CK isoenzyme produced by these cell lines was CK-BB, well known to be a heat-labile isoenzyme. Table 9 shows the significant decrease of CK activity with storage as a reflection of the high concentration of CK-BB isoenzyme of the material.
The EK cell strain we selected for CK production also produces mainly CK-BB isoenzyme. Recently, we found a cell strain that produced a high activity of CK-MM, but the total CK productivity of that cell strain was lower than that of the EK strain. These results suggest that human cultured cells do not always ensure enzymes with properties similar to those of the counterpart enzymes in normal human serum.
Not only the CK-MM but also the ALT of our human cell culture systems are relatively low producing; we are still trying to find highly productive systems for these enzymes.
The specific enzyme productivity of a cell line directly influences the cost of the product through determining the size of production equipment and the amount of FBS consumed per unit of enzyme activity produced. 
